Biotechnology Portfolio Mutual Fund Forecast - Simple Moving Average
| FBIOX Fund | USD 26.19 0.46 1.79% |
The Simple Moving Average forecasted value of Biotechnology Portfolio Biotechnology on the next trading day is expected to be 26.19 with a mean absolute deviation of 0.29 and the sum of the absolute errors of 17.52. BIOTECHNOLOGY Mutual Fund Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of Biotechnology Portfolio's share price is below 20 . This usually indicates that the mutual fund is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Biotechnology Portfolio hype-based prediction, you can estimate the value of Biotechnology Portfolio Biotechnology from the perspective of Biotechnology Portfolio response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Biotechnology Portfolio Biotechnology on the next trading day is expected to be 26.19 with a mean absolute deviation of 0.29 and the sum of the absolute errors of 17.52. Biotechnology Portfolio after-hype prediction price | USD 26.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BIOTECHNOLOGY |
Biotechnology Portfolio Additional Predictive Modules
Most predictive techniques to examine BIOTECHNOLOGY price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BIOTECHNOLOGY using various technical indicators. When you analyze BIOTECHNOLOGY charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Biotechnology Portfolio Simple Moving Average Price Forecast For the 24th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Biotechnology Portfolio Biotechnology on the next trading day is expected to be 26.19 with a mean absolute deviation of 0.29, mean absolute percentage error of 0.13, and the sum of the absolute errors of 17.52.Please note that although there have been many attempts to predict BIOTECHNOLOGY Mutual Fund prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biotechnology Portfolio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Biotechnology Portfolio Mutual Fund Forecast Pattern
| Backtest Biotechnology Portfolio | Biotechnology Portfolio Price Prediction | Buy or Sell Advice |
Biotechnology Portfolio Forecasted Value
In the context of forecasting Biotechnology Portfolio's Mutual Fund value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biotechnology Portfolio's downside and upside margins for the forecasting period are 24.89 and 27.49, respectively. We have considered Biotechnology Portfolio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Biotechnology Portfolio mutual fund data series using in forecasting. Note that when a statistical model is used to represent Biotechnology Portfolio mutual fund, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.2444 |
| Bias | Arithmetic mean of the errors | -0.0788 |
| MAD | Mean absolute deviation | 0.2921 |
| MAPE | Mean absolute percentage error | 0.0118 |
| SAE | Sum of the absolute errors | 17.525 |
Predictive Modules for Biotechnology Portfolio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotechnology Portfolio. Regardless of method or technology, however, to accurately forecast the mutual fund market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the mutual fund market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotechnology Portfolio After-Hype Price Prediction Density Analysis
As far as predicting the price of Biotechnology Portfolio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biotechnology Portfolio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Mutual Fund prices, such as prices of Biotechnology Portfolio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biotechnology Portfolio Estimiated After-Hype Price Volatility
In the context of predicting Biotechnology Portfolio's mutual fund value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biotechnology Portfolio's historical news coverage. Biotechnology Portfolio's after-hype downside and upside margins for the prediction period are 24.90 and 27.50, respectively. We have considered Biotechnology Portfolio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biotechnology Portfolio is very steady at this time. Analysis and calculation of next after-hype price of Biotechnology Portfolio is based on 3 months time horizon.
Biotechnology Portfolio Mutual Fund Price Prediction Analysis
Have you ever been surprised when a price of a Mutual Fund such as Biotechnology Portfolio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biotechnology Portfolio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Fund price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biotechnology Portfolio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.21 | 1.30 | 0.01 | 0.09 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
26.19 | 26.20 | 0.04 |
|
Biotechnology Portfolio Hype Timeline
Biotechnology Portfolio is currently traded for 26.19. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.09. BIOTECHNOLOGY is estimated to increase in value after the next headline, with the price projected to jump to 26.2 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.04%, whereas the daily expected return is currently at 0.21%. The volatility of related hype on Biotechnology Portfolio is about 309.52%, with the expected price after the next announcement by competition of 26.28. Assuming the 90 days horizon the next estimated press release will be very soon. Check out Historical Fundamental Analysis of Biotechnology Portfolio to cross-verify your projections.Biotechnology Portfolio Related Hype Analysis
Having access to credible news sources related to Biotechnology Portfolio's direct competition is more important than ever and may enhance your ability to predict Biotechnology Portfolio's future price movements. Getting to know how Biotechnology Portfolio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biotechnology Portfolio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FSPHX | Health Care Portfolio | (0.16) | 1 per month | 0.56 | 0.06 | 1.74 | (1.07) | 5.07 | |
| FSPTX | Technology Portfolio Technology | (0.01) | 1 per month | 1.43 | 0.04 | 2.09 | (2.44) | 9.32 | |
| FSELX | Fidelity Select Semiconductors | 0.60 | 3 per month | 1.97 | 0.09 | 3.75 | (3.66) | 10.78 | |
| FSCSX | Software And It | 0.00 | 0 per month | 1.39 | (0.01) | 1.82 | (2.46) | 18.04 | |
| FBSOX | It Services Portfolio | 1.67 | 4 per month | 0.00 | (0.14) | 1.64 | (2.22) | 4.77 |
Other Forecasting Options for Biotechnology Portfolio
For every potential investor in BIOTECHNOLOGY, whether a beginner or expert, Biotechnology Portfolio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BIOTECHNOLOGY Mutual Fund price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BIOTECHNOLOGY. Basic forecasting techniques help filter out the noise by identifying Biotechnology Portfolio's price trends.Biotechnology Portfolio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biotechnology Portfolio Market Strength Events
Market strength indicators help investors to evaluate how Biotechnology Portfolio mutual fund reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biotechnology Portfolio shares will generate the highest return on investment. By undertsting and applying Biotechnology Portfolio mutual fund market strength indicators, traders can identify Biotechnology Portfolio Biotechnology entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 26.19 | |||
| Day Typical Price | 26.19 | |||
| Price Action Indicator | 0.23 | |||
| Period Momentum Indicator | 0.46 |
Biotechnology Portfolio Risk Indicators
The analysis of Biotechnology Portfolio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biotechnology Portfolio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biotechnology mutual fund prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.02 | |||
| Semi Deviation | 1.16 | |||
| Standard Deviation | 1.32 | |||
| Variance | 1.74 | |||
| Downside Variance | 1.78 | |||
| Semi Variance | 1.34 | |||
| Expected Short fall | (1.11) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biotechnology Portfolio
The number of cover stories for Biotechnology Portfolio depends on current market conditions and Biotechnology Portfolio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biotechnology Portfolio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biotechnology Portfolio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Other Information on Investing in BIOTECHNOLOGY Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether BIOTECHNOLOGY Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTECHNOLOGY with respect to the benefits of owning Biotechnology Portfolio security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |